Blue Enriched Versus Standard Light Treatment for Seasonal Affective Disorder(SAD)
Gerandomiseerde en Gecontroleerde Studie Naar de Effecten Van Lichttoediening Met Een Hogere Kleurtemperatuur in Vergelijking Met de Standaard Lichttherapie in de Behandeling Van Winterdepressie
1 other identifier
interventional
52
1 country
1
Brief Summary
One of the most frequently investigated hypothesis of the pathophysiology underlying Seasonal Affective Disorder(SAD) or so called winterdepression is a disturbance of circadian rhythms. Since the circadian system is especially sensitive for the blue portion of the light spectrum, a new light therapy device with more blue light (blue enriched polychromatic light) was tested for its efficacy to treat SAD. In chronobiological terms this light is hypothesized to be more potent in inducing non-visual effects. In the present study fluorescent tubes that emit a high portion of short wavelength light on top of the normal wavelengths are tested for its superiority in treating SAD. This blue-enriched light (colour temperature 17000 ºK) is compared to standard light treatment (5000 º K) in SAD patients., The investigators hypothesise that blue- enriched light improve the therapeutic effects of light treatment leading to a higher response or the same response in a shorter time schedule compared to standard light treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2005
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 12, 2010
CompletedFirst Posted
Study publicly available on registry
January 13, 2010
CompletedJanuary 13, 2010
October 1, 2005
5 months
January 12, 2010
January 12, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SIGH SAD depression observer rating
days 1, 8, 15, 22
Secondary Outcomes (1)
selfrating of depressive mood
once daily during 22 days
Study Arms (3)
Standard Light Treatment
ACTIVE COMPARATOR30 min of Standard bright light treatment (color 5000K)
Blue enriched Light treatment 20 min
EXPERIMENTAL20 minutes of Blue enriched light treatment (color 17000K)
Blue enriched light treatment 30 min
EXPERIMENTAL30 minutes of Blue enriched light treatment (color 17000K)
Interventions
9000 lux, 30 minutes in the morning
9000 lux 20 minutes in the morning
Eligibility Criteria
You may qualify if:
- age 18-65;
- diagnosis of Seasonal affective Disorder, winter type according to DSM-IV;
- SIGH SAD rating higher then or equal to 18 on day 1;
- no other treatments for mood disorder during the study
- stay in the Netherlands during the study
You may not qualify if:
- other Axis 1 disorder according to DSM-IV
- acute suicide risk
- use of psychotropic drugs or photosensitizing drugs
- eye diseases other then usual effect of aging
- diabetes or epilepsy
- regular shift work
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, University Medical Center Groningen
Groningen, 9700RB, Netherlands
Related Publications (1)
Gordijn MCM, 't Mannetje D, Meesters Y. The effects of blue-enriched light treatment compared to standard light treatment in Seasonal Affective Disorder. J Affect Disord. 2012 Jan;136(1-2):72-80. doi: 10.1016/j.jad.2011.08.016. Epub 2011 Sep 10.
PMID: 21911257DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Y. Meesters, PhD
Department of Psychiatry, University Medical Center Groningen, The Netherlands
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 12, 2010
First Posted
January 13, 2010
Study Start
October 1, 2005
Primary Completion
March 1, 2006
Study Completion
March 1, 2006
Last Updated
January 13, 2010
Record last verified: 2005-10